Search
for
Sort by
Research 91–120 of 1000+
- Atypical Progeroid Syndrome due to Heterozygous Missense LMNA Mutations
- Clinical biochemistry of dihydrotestosterone
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Update on polycystic ovary syndrome
- POLYCYSTIC OVARY SYNDROME (PCOS): DIAGNOSIS, PATHOPHYSIOLOGY AND CONTEMPORARY THERAPEUTIC APPROACHES
- Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
- Sex differences in arterial hypertension
- Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
- Biochemical and Structural Characteristics, Gene Regulation, Physiological, Pathological and Clinical Features of Lipocalin-Type Prostaglandin D2 Synthase as a Multifunctional Lipocalin
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Translating Resveratrol Research: A Systematic Review on Patents and Clinical Trials (2000–2025)
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- Perspective Chapter: Beyond BMI – Rethinking Obesity Assessment in Women’s Health
- Ageing-Related Features of Hair and Scalp in Chinese Women by Clinical Evaluation Study
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Endocrine intervention for transsexuals
- The X Factor in Immunity: Sex Differences Shaped by the X Chromosome
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Clinical use of 5α-reductase inhibitors
- DRUG‐ASSOCIATED ALOPECIA
- Finasteride Blocks the Reduction in Ictal Activity Produced by Exogenous Estrous Cyclicity
- Endocrine evaluation of hirsutism
- Alterations in Hair Follicle Dynamics in Women
- Endocrine evaluation of hirsutism
- Sebum Production